Hoarseness (Dysphonia)
Key Points
Table 1. Summary of Guideline Key Action Statements (KAS)
Diagnosis
Identification of Abnormal Voice
Identifying Underlying Cause of Dysphonia
Escalation of Care
Laryngoscopy and Dysphonia
Need for Laryngoscopy in Persistent Dysphonia
Imaging
Treatment
Anti-Reflux Medication and Dysphonia
Corticosteroid Therapy
Antimicrobial Therapy
Laryngoscopy Prior to Voice Therapy
Advocating for Voice Therapy
Surgery
Botulinum Toxin
Education/ Prevention
Outcomes
Recommendation Grading
Disclaimer
Overview
Title
Hoarseness (Dysphonia)
Authoring Organization
American Academy of Otolaryngology - Head and Neck Surgery Foundation
Endorsing Organizations
American Academy of Otolaryngic Allergy
American Academy of Pediatrics
American Academy of Physical Medicine and Rehabilitation
American College of Chest Physicians
Society of Otorhinolaryngology and Head-Neck Nurses
American Speech-Language-Hearing Association
Publication Month/Year
March 1, 2018
Last Updated Month/Year
August 7, 2023
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
The primary purpose of this guideline is to improve the quality of care for patients with dysphonia, based on current best evidence.
Target Patient Population
All individuals presenting with dysphonia, regardless of age
Target Provider Population
All clinicians who diagnose and treat patients with dysphonia
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Childcare center, Long term care, Outpatient, School
Intended Users
Speech language pathologist, physician, nurse, nurse practitioner, physician assistant
Scope
Diagnosis, Prevention, Management, Treatment
Diseases/Conditions (MeSH)
D006685 - Hoarseness, D055154 - Dysphonia, D007827 - Laryngitis
Keywords
dysphonia, hoarseness, voice change, voice disturbance, voice disorders, laryngitis, voice